Ovid Therapeutics (OVID) Change in Account Payables (2016 - 2026)
Ovid Therapeutics (OVID) posted Change in Account Payables of $3.6 million for Q1 2026, up 1373.17% on a QoQ basis from $246000.0 in Q4 2025, and up 391.79% year-over-year from $736903.7 in Q1 2025.
Ovid Therapeutics (OVID) Change in Account Payables (2016 - 2026) Analysis & Trends
Ovid Therapeutics' Change in Account Payables history runs 11 years deep, the most recent figure standing at $3.6 million for Q1 2026.
- Quarterly Change in Account Payables rose 391.79% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (up 320.52% YoY) and the FY2025 annual result came in at -$1.2 million, down 141.02% from the prior year.
- Change in Account Payables was $3.6 million for Q1 2026 at Ovid Therapeutics, up from $246000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $3.6 million in Q1 2026 and bottomed at -$4.9 million in Q1 2022.
- A 5-year average of -$90949.2 and a median of $246000.0 in 2025 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2025 — Change in Account Payables plunged 1060.75% — and 2026, when it surged 391.79%.
- Ovid Therapeutics' Change in Account Payables stood at $919844.0 in 2022, then surged by 170.26% to $2.5 million in 2023, then plunged by 80.65% to $481000.0 in 2024, then tumbled by 48.86% to $246000.0 in 2025, then jumped by 1373.17% to $3.6 million in 2026.
- Business Quant data shows OVID's Change in Account Payables at $3.6 million in Q1 2026, $246000.0 in Q4 2025, and -$2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 16.86 Mn |
| 10 | Ovid Therapeutics | 118.66 Mn | -36.86 Mn | - | 3.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.62 Mn |
| Mar 31, 2026 | 3.62 Mn |
| Dec 31, 2025 | 246,000.00 |
| Dec 31, 2025 | 246,000.00 |
| Sep 30, 2025 | -2.24 Mn |
| Sep 30, 2025 | -2.24 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | -1.24 Mn |
| Mar 31, 2025 | -1.24 Mn |
| Dec 31, 2024 | 481,000.00 |
| Dec 31, 2024 | 481,000.00 |
| Sep 30, 2024 | -2.01 Mn |
| Sep 30, 2024 | -2.01 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Mar 31, 2024 | -107,000.00 |
| Mar 31, 2024 | -107,000.00 |
| Dec 31, 2023 | 2.49 Mn |
| Dec 31, 2023 | 2.49 Mn |